Status:
UNKNOWN
Light Therapy Plus Exercise to Improve Motor, Non-Motor Symptoms and QoL in Parkinson's Disease
Lead Sponsor:
Gaitway Neurophysio
Conditions:
Parkinson's
Disease
Eligibility:
All Genders
55-80 years
Phase:
NA
Brief Summary
Parkinson's disease (PD) is a lifelong and progressive disease and is the second most common progressive neurodegenerative disease worldwide. This study will examine whether there are significant dif...
Detailed Description
Parkinson's disease (PD) is a lifelong and progressive disease; symptoms slowly worsen over time. PD worldwide is the second most common progressive neurodegenerative disease after Alzheimer's disease...
Eligibility Criteria
Inclusion
- Neurologist-diagnosed Hoehn and Yahr Stages 2-3 (moderate) idiopathic PD;
- With or without anti-Parkinson's Disease medications;
- Able to attend the PD Wellness \& Innovation Centre in Hamilton, Ontario, Canada,
- Participating in exercise program prior to enrolment
Exclusion
- Previous PBM treatment
- MOCA score of ≤23/30
- Insufficient understanding of English to sign an informed consent, understand teaching and to perform at-home PBM treatment
- Physically unable to perform tasks required for outcome measurement testing
- History of significant unstable musculoskeletal or neurological disorders or unstable cardiac condition
Key Trial Info
Start Date :
January 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06036433
Start Date
January 2 2023
End Date
May 1 2024
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaitway Neurophysio and Parkinson's Wellness Innovation Centre
Hamilton, Ontario, Canada, L8P 2B6